Gene · 3663
Papers4,211
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 4,211
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Senescence-related gene c-Myc affects bladder cancer cell senescence by interacting with HSP90B1 to regulate cisplatin sensitivity. | Aging (Albany NY) | 2023 | 37433010 | PubTator, text mining | PubMed |
| Advanced methods and novel biomarkers in autoimmune diseases ‑ a review of the recent years progress in systemic lupus erythematosus. | Front Med (Lausanne) | 2023 | 37425332 | PubTator, text mining | PubMed |
| Neural lineage differentiation of human pluripotent stem cells: Advances in disease modeling. | World J Stem Cells | 2023 | 37424945 | PubTator, text mining | PubMed |
| Whole-exome sequencing identified the mutation of IRF5 in thymic Rosai-Dorfman disease: A case report. | Asian J Surg | 2023 | 37422400 | PubTator, text mining | PubMed |
| Autoimmune liver disease and multiple sclerosis: state of the art and future perspectives. | Clin Exp Med | 2023 | 37421590 | PubTator, text mining | PubMed |
| B cell receptor-induced protein dynamics and the emerging role of SUMOylation revealed by proximity proteomics. | J Cell Sci | 2023 | 37417469 | PubTator, text mining | PubMed |
| Advancements in understanding the role of microRnas in regulating macrophage polarization during acute lung injury. | Cell Cycle | 2023 | 37415386 | PubTator, text mining | PubMed |
| TRAF2 promotes M2-polarized tumor-associated macrophage infiltration, angiogenesis and cancer progression by inhibiting autophagy in clear cell renal cell carcinoma. | J Exp Clin Cancer Res | 2023 | 37415241 | PubTator, text mining | PubMed |
| CYP4F12 is a potential biomarker and inhibits cell migration of head and neck squamous cell carcinoma via EMT pathway. | Sci Rep | 2023 | 37414830 | PubTator, text mining | PubMed |
| The Role of Regulatory T Cells in the Onset and Progression of Primary Sjögren's Syndrome. | Cells | 2023 | 37408193 | PubTator, text mining | PubMed |
| A New Methodology for the Quantification of Neutrophil Extracellular Traps in Patient Plasma. | Bio Protoc | 2023 | 37397793 | PubTator, text mining | PubMed |
| Regulation of IFNβ expression: focusing on the role of its promoter and transcription regulators. | Front Microbiol | 2023 | 37396372 | PubTator, text mining | PubMed |
| Multidimensional definition of the interferonopathy of Down syndrome and its response to JAK inhibition. | Sci Adv | 2023 | 37379383 | PubTator, text mining | PubMed |
| Neutrophils in Cancer and Potential Therapeutic Strategies Using Neutrophil-Derived Exosomes. | Vaccines (Basel) | 2023 | 37376417 | PubTator, text mining | PubMed |
| Polymers and Bioactive Compounds with a Macrophage Modulation Effect for the Rational Design of Hydrogels for Skin Regeneration. | Pharmaceutics | 2023 | 37376103 | PubTator, text mining | PubMed |
| Disentangling the Pathogenesis of Systemic Lupus Erythematosus: Close Ties between Immunological, Genetic and Environmental Factors. | Medicina (Kaunas) | 2023 | 37374237 | PubTator, text mining | PubMed |
| The Spectrum of Extraglandular Manifestations in Primary Sjögren's Syndrome. | J Pers Med | 2023 | 37373950 | PubTator, text mining | PubMed |
| The Preventive Mechanisms of Bioactive Food Compounds against Obesity-Induced Inflammation. | Antioxidants (Basel) | 2023 | 37371961 | PubTator, text mining | PubMed |
| Exosomes: A Promising Strategy for Repair, Regeneration and Treatment of Skin Disorders. | Cells | 2023 | 37371095 | PubTator, text mining | PubMed |
| Recent Advances in CAR-Based Solid Tumor Immunotherapy. | Cells | 2023 | 37371075 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3663/papers?page=21